Skip to main content
Top

05-04-2024 | Acute Liver Failure | Narrative review

Critical care management of acute liver failure

Authors: Surender Singh Sehrawat, Madhumita Premkumar

Published in: Indian Journal of Gastroenterology

Login to get access

Abstract

The management of acute liver failure (ALF) in modern hepatology intensive care units (ICU) has improved patient outcomes. Critical care management of hepatic encephalopathy, cerebral edema, fluid and electrolytes; prevention of infections and organ support are central to improved outcomes of ALF. In particular, the pathogenesis of encephalopathy is multifactorial, with ammonia, elevated intra-cranial pressure and systemic inflammation playing a central role. Although ALF remains associated with high mortality, the availability of supportive care, including organ failure support such as plasma exchange, timely mechanical ventilation or continuous renal replacement therapy, either conservatively manages patients with ALF or offers bridging therapy until liver transplantation. Thus, appropriate critical care management has improved the likelihood of patient recovery in ALF. ICU care interventions such as monitoring of cerebral edema, fluid status assessment and interventions for sepsis prevention, nutritional support and management of electrolytes can salvage a substantial proportion of patients. In this review, we discuss the key aspects of critical care management of ALF.
Appendix
Available only for authorised users
Literature
1.
go back to reference European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu;, Clinical practice guidelines panel, Wendon J, Panel members, Cordoba J, Dhawan A, et al. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J Hepatol. 2017;66:1047–81. European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu;, Clinical practice guidelines panel, Wendon J, Panel members, Cordoba J, Dhawan A, et al. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J Hepatol. 2017;66:1047–81.
2.
go back to reference Anand AC, Nandi B, Acharya SK, et al. Indian National Association for the Study of the Liver Consensus Statement on Acute Liver Failure (Part 1): epidemiology, pathogenesis, presentation and prognosis. J Clin Exp Hepatol. 2020;10:339–76.PubMedPubMedCentralCrossRef Anand AC, Nandi B, Acharya SK, et al. Indian National Association for the Study of the Liver Consensus Statement on Acute Liver Failure (Part 1): epidemiology, pathogenesis, presentation and prognosis. J Clin Exp Hepatol. 2020;10:339–76.PubMedPubMedCentralCrossRef
3.
go back to reference Polson J, Lee WM. American Association for the Study of Liver Disease. AASLD position paper: the management of acute liver failure. Hepatology. 2005;41:1179–97. Polson J, Lee WM. American Association for the Study of Liver Disease. AASLD position paper: the management of acute liver failure. Hepatology. 2005;41:1179–97.
4.
go back to reference Stravitz RT, Lisman T, Luketic VA, et al. Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography. J Hepatol. 2012;56:129–36.PubMedCrossRef Stravitz RT, Lisman T, Luketic VA, et al. Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography. J Hepatol. 2012;56:129–36.PubMedCrossRef
5.
go back to reference Tandon BN, Bernauau J, O’Grady J, et al. Recommendations of the International Association for the Study of the Liver Subcommittee on nomenclature of acute and subacute liver failure. J Gastroenterol Hepatol. 1999;14:403–4.PubMedCrossRef Tandon BN, Bernauau J, O’Grady J, et al. Recommendations of the International Association for the Study of the Liver Subcommittee on nomenclature of acute and subacute liver failure. J Gastroenterol Hepatol. 1999;14:403–4.PubMedCrossRef
6.
go back to reference Tujios SR, Lee WM. Acute liver failure induced by idiosyncratic reaction to drugs: challenges in diagnosis and therapy. Liver Int. 2018;38:6–14.PubMedCrossRef Tujios SR, Lee WM. Acute liver failure induced by idiosyncratic reaction to drugs: challenges in diagnosis and therapy. Liver Int. 2018;38:6–14.PubMedCrossRef
9.
10.
go back to reference Rao A, Rule JA, Cerro-Chiang G, et al. Role of hepatitis c infection in acute liver injury/acute liver failure in North America. Dig Dis Sci. 2023;68:304–11.PubMedCrossRef Rao A, Rule JA, Cerro-Chiang G, et al. Role of hepatitis c infection in acute liver injury/acute liver failure in North America. Dig Dis Sci. 2023;68:304–11.PubMedCrossRef
11.
12.
go back to reference Gupta E, Ballani N, Kumar M, Sarin SK. Role of non-hepatotropic viruses in acute sporadic viral hepatitis and acute-on-chronic liver failure in adults. Indian J Gastroenterol. 2015;34:448–52.PubMedCrossRef Gupta E, Ballani N, Kumar M, Sarin SK. Role of non-hepatotropic viruses in acute sporadic viral hepatitis and acute-on-chronic liver failure in adults. Indian J Gastroenterol. 2015;34:448–52.PubMedCrossRef
13.
go back to reference Rabaan AA, Bakhrebah MA, Nassar MS, et al. Suspected adenovirus causing an emerging HEPATITIS among children below 10 years: a review. Pathogens. 2022;11:712.PubMedPubMedCentralCrossRef Rabaan AA, Bakhrebah MA, Nassar MS, et al. Suspected adenovirus causing an emerging HEPATITIS among children below 10 years: a review. Pathogens. 2022;11:712.PubMedPubMedCentralCrossRef
14.
go back to reference Mellinger JL, Rossaro L, Naugler WE, et al. Epstein-Barr virus (EBV) related acute liver failure: a case series from the US Acute Liver Failure Study Group. Dig Dis Sci. 2014;59:1630–7.PubMedPubMedCentralCrossRef Mellinger JL, Rossaro L, Naugler WE, et al. Epstein-Barr virus (EBV) related acute liver failure: a case series from the US Acute Liver Failure Study Group. Dig Dis Sci. 2014;59:1630–7.PubMedPubMedCentralCrossRef
15.
go back to reference Archer JS. Acute liver failure in pregnancy. A case report. J Reprod Med. 2001;46:137–40.PubMed Archer JS. Acute liver failure in pregnancy. A case report. J Reprod Med. 2001;46:137–40.PubMed
16.
17.
go back to reference Song ATW, Carneiro D’Albuquerque LA. Acute liver failure secondary to yellow fever: a challenging scenario. Clin Liver Dis (Hoboken). 2019;13:58–61.PubMedPubMedCentralCrossRef Song ATW, Carneiro D’Albuquerque LA. Acute liver failure secondary to yellow fever: a challenging scenario. Clin Liver Dis (Hoboken). 2019;13:58–61.PubMedPubMedCentralCrossRef
20.
go back to reference Lee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: summary of a workshop. Hepatology. 2008;47:1401–15.PubMedCrossRef Lee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: summary of a workshop. Hepatology. 2008;47:1401–15.PubMedCrossRef
22.
go back to reference Karvellas CJ, Stravitz RT. Acute liver failure. In: Arun J. Sanyal TDB, Norah A, Terrault, Keith D, Lindor, editors. Zakim and Boyer’s Hepatology: A Textbook of Liver Disease. 7th ed. Philadelphia, PA: Elsevier; 2018. p. 19103–2899. Karvellas CJ, Stravitz RT. Acute liver failure. In: Arun J. Sanyal TDB, Norah A, Terrault, Keith D, Lindor, editors. Zakim and Boyer’s Hepatology: A Textbook of Liver Disease. 7th ed. Philadelphia, PA: Elsevier; 2018. p. 19103–2899.
23.
go back to reference Eapen CE, Venkataraman J. Rodenticide (yellow phosphorus poison)-induced hepatotoxicity in India: constraints during management. J Clin Exp Hepatol. 2021;11:414–7.PubMedPubMedCentralCrossRef Eapen CE, Venkataraman J. Rodenticide (yellow phosphorus poison)-induced hepatotoxicity in India: constraints during management. J Clin Exp Hepatol. 2021;11:414–7.PubMedPubMedCentralCrossRef
24.
go back to reference Santi L, Maggioli C, Mastroroberto M, Tufoni M, Napoli L, Caraceni P. Acute liver failure caused by Amanita phalloides poisoning. Int J Hepatol. 2012;2012:487480. Santi L, Maggioli C, Mastroroberto M, Tufoni M, Napoli L, Caraceni P. Acute liver failure caused by Amanita phalloides poisoning. Int J Hepatol. 2012;2012:487480.
25.
go back to reference Phan T, Desmond C. Hepatitis E infection with acute liver failure. ACG Case Rep J. 2020;7:e00361. Phan T, Desmond C. Hepatitis E infection with acute liver failure. ACG Case Rep J. 2020;7:e00361.
26.
go back to reference Anand AC, Nandi B, Acharya SK, et al. Indian National Association for the Study of Liver Consensus Statement on Acute Liver Failure (Part-2): management of acute liver failure. J Clin Exp Hepatol. 2020;10:477–517.PubMedPubMedCentralCrossRef Anand AC, Nandi B, Acharya SK, et al. Indian National Association for the Study of Liver Consensus Statement on Acute Liver Failure (Part-2): management of acute liver failure. J Clin Exp Hepatol. 2020;10:477–517.PubMedPubMedCentralCrossRef
27.
go back to reference Casey LC, Fontana RJ, Aday A, et al. Acute liver failure (ALF) in pregnancy: how much is pregnancy related? Hepatology. 2020;72:1366–77. Casey LC, Fontana RJ, Aday A, et al. Acute liver failure (ALF) in pregnancy: how much is pregnancy related? Hepatology. 2020;72:1366–77.
28.
go back to reference De Martin E, Coilly A, Houssel-Debry P, et al. Treatment and prognosis of acute severe autoimmune hepatitis. J Hepatology. 2017;1:S4.CrossRef De Martin E, Coilly A, Houssel-Debry P, et al. Treatment and prognosis of acute severe autoimmune hepatitis. J Hepatology. 2017;1:S4.CrossRef
29.
go back to reference Seetharam A. Intensive care management of acute liver failure: considerations while awaiting liver transplantation. J Clin Translation Hepatol. 2019;7:384. Seetharam A. Intensive care management of acute liver failure: considerations while awaiting liver transplantation. J Clin Translation Hepatol. 2019;7:384.
31.
go back to reference Montrief T, Koyfman A, Long B. Acute liver failure: a review for emergency physicians. Ame J Emerg Med. 2019;37:329–37.CrossRef Montrief T, Koyfman A, Long B. Acute liver failure: a review for emergency physicians. Ame J Emerg Med. 2019;37:329–37.CrossRef
32.
go back to reference O’Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97:439–45.CrossRef O’Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97:439–45.CrossRef
33.
go back to reference Kumar R, Shalimar, Sharma H, et al. Prospective derivation and validation of early dynamic model for predicting outcome in patients with acute liver failure. Gut. 2012;61:1068–75. Kumar R, Shalimar, Sharma H, et al. Prospective derivation and validation of early dynamic model for predicting outcome in patients with acute liver failure. Gut. 2012;61:1068–75.
34.
go back to reference Dhiman RK, Jain S, Maheshwari U, et al. Early indicators of prognosis in fulminant hepatic failure: an assessment of the model for end-stage liver disease (MELD) and King’s College Hospital criteria. Liver Transpl. 2007;13:814–21.PubMedCrossRef Dhiman RK, Jain S, Maheshwari U, et al. Early indicators of prognosis in fulminant hepatic failure: an assessment of the model for end-stage liver disease (MELD) and King’s College Hospital criteria. Liver Transpl. 2007;13:814–21.PubMedCrossRef
35.
go back to reference Craig DG, Ford AC, Hayes PC, Simpson KJ. Systematic review: prognostic tests of paracetamol-induced acute liver failure. Aliment Pharmacol Ther. 2010;31:1064–76.PubMedCrossRef Craig DG, Ford AC, Hayes PC, Simpson KJ. Systematic review: prognostic tests of paracetamol-induced acute liver failure. Aliment Pharmacol Ther. 2010;31:1064–76.PubMedCrossRef
36.
go back to reference McPhail MJ, Wendon JA, Bernal W. Meta-analysis of performance of King’s College Hospital Criteria in prediction of outcome in non-paracetamol-induced acute liver failure. J Hepatol. 2010;53:492–9.PubMedCrossRef McPhail MJ, Wendon JA, Bernal W. Meta-analysis of performance of King’s College Hospital Criteria in prediction of outcome in non-paracetamol-induced acute liver failure. J Hepatol. 2010;53:492–9.PubMedCrossRef
37.
go back to reference Schmidt LE, Larsen FS. MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury. Hepatology. 2007;45:789–96.PubMedCrossRef Schmidt LE, Larsen FS. MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury. Hepatology. 2007;45:789–96.PubMedCrossRef
38.
go back to reference Bernuau J, Goudeau A, Poynard T, et al. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology. 1986;6:648–51.PubMedCrossRef Bernuau J, Goudeau A, Poynard T, et al. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology. 1986;6:648–51.PubMedCrossRef
39.
go back to reference Lin CH, Chen CL, Lin TK, Chen NC, Tsai MH, Chuang YC. Levetiracetam in the treatment of epileptic seizures after liver transplantation. Medicine (Baltimore). 2015;94:e1350. Lin CH, Chen CL, Lin TK, Chen NC, Tsai MH, Chuang YC. Levetiracetam in the treatment of epileptic seizures after liver transplantation. Medicine (Baltimore). 2015;94:e1350.
41.
go back to reference Canalese J, Gimson AE, Davis C, Mellon PJ, Davis M, Williams R. Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure. Gut. 1982;23:625–9.PubMedPubMedCentralCrossRef Canalese J, Gimson AE, Davis C, Mellon PJ, Davis M, Williams R. Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure. Gut. 1982;23:625–9.PubMedPubMedCentralCrossRef
42.
go back to reference Lee WM, Hynan LS, Rossaro L, et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology. 2009;137:856-64, 64 e1. Lee WM, Hynan LS, Rossaro L, et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology. 2009;137:856-64, 64 e1.
43.
go back to reference Ede RJ, Gimson AE, Bihari D, Williams R. Controlled hyperventilation in the prevention of cerebral oedema in fulminant hepatic failure. J Hepatol. 1986;2:43–51.PubMedCrossRef Ede RJ, Gimson AE, Bihari D, Williams R. Controlled hyperventilation in the prevention of cerebral oedema in fulminant hepatic failure. J Hepatol. 1986;2:43–51.PubMedCrossRef
44.
go back to reference Jalan R, Olde Damink SW, Deutz NE, et al. Moderate hypothermia prevents cerebral hyperemia and increase in intracranial pressure in patients undergoing liver transplantation for acute liver failure. Transplantation. 2003;75:2034–9.PubMedCrossRef Jalan R, Olde Damink SW, Deutz NE, et al. Moderate hypothermia prevents cerebral hyperemia and increase in intracranial pressure in patients undergoing liver transplantation for acute liver failure. Transplantation. 2003;75:2034–9.PubMedCrossRef
45.
go back to reference Dart RC, Mullins ME, Matoushek T, et al. Management of acetaminophen poisoning in the US and Canada: a consensus statement. JAMA Netw Open. 2023;6:e2327739. Dart RC, Mullins ME, Matoushek T, et al. Management of acetaminophen poisoning in the US and Canada: a consensus statement. JAMA Netw Open. 2023;6:e2327739.
46.
go back to reference Floersheim GL, Eberhard M, Tschumi P, Duckert F. Effects of penicillin and silymarin on liver enzymes and blood clotting factors in dogs given a boiled preparation of Amanita phalloides. Toxicol Appl Pharmacol. 1978;46:455–62. Floersheim GL, Eberhard M, Tschumi P, Duckert F. Effects of penicillin and silymarin on liver enzymes and blood clotting factors in dogs given a boiled preparation of Amanita phalloides. Toxicol Appl Pharmacol. 1978;46:455–62.
47.
go back to reference Koppel C. Clinical symptomatology and management of mushroom poisoning. Toxicon. 1993;31:1513–40.PubMedCrossRef Koppel C. Clinical symptomatology and management of mushroom poisoning. Toxicon. 1993;31:1513–40.PubMedCrossRef
48.
go back to reference Fujiwara K, Yasui S, Haga Y, et al. Early combination therapy with corticosteroid and nucleoside analogue induces rapid resolution of inflammation in acute liver failure due to transient hepatitis B virus infection. Intern Med. 2018;57:1543–52. Fujiwara K, Yasui S, Haga Y, et al. Early combination therapy with corticosteroid and nucleoside analogue induces rapid resolution of inflammation in acute liver failure due to transient hepatitis B virus infection. Intern Med. 2018;57:1543–52.
49.
go back to reference Goya T, Kurashige T, Kurokawa M, et al. The combination of nucleotide analog therapy and steroid pulse therapy for acute HBV infection effectively promotes HBV clearance. Gastroenterology Insights. 2021;13:1–8.CrossRef Goya T, Kurashige T, Kurokawa M, et al. The combination of nucleotide analog therapy and steroid pulse therapy for acute HBV infection effectively promotes HBV clearance. Gastroenterology Insights. 2021;13:1–8.CrossRef
50.
go back to reference Ichai P, Roque Afonso AM, Sebagh M, et al. Herpes simplex virus-associated acute liver failure: a difficult diagnosis with a poor prognosis. Liver Transpl. 2005;11:1550–5.PubMedCrossRef Ichai P, Roque Afonso AM, Sebagh M, et al. Herpes simplex virus-associated acute liver failure: a difficult diagnosis with a poor prognosis. Liver Transpl. 2005;11:1550–5.PubMedCrossRef
51.
go back to reference Karkhanis J, Verna EC, Chang MS, et al. Steroid use in acute liver failure. Hepatology. 2014;59:612–21.PubMedCrossRef Karkhanis J, Verna EC, Chang MS, et al. Steroid use in acute liver failure. Hepatology. 2014;59:612–21.PubMedCrossRef
52.
go back to reference Sen S, Felldin M, Steiner C, et al. Albumin dialysis and molecular adsorbents recirculating system (MARS) for acute Wilson’s disease. Liver Transpl. 2002;8:962–7.PubMedCrossRef Sen S, Felldin M, Steiner C, et al. Albumin dialysis and molecular adsorbents recirculating system (MARS) for acute Wilson’s disease. Liver Transpl. 2002;8:962–7.PubMedCrossRef
53.
go back to reference Pham HP, Schwartz J, Cooling L, et al. Report of the ASFA apheresis registry study on Wilson’s disease. J Clin Apher. 2016;31:11–5.PubMedCrossRef Pham HP, Schwartz J, Cooling L, et al. Report of the ASFA apheresis registry study on Wilson’s disease. J Clin Apher. 2016;31:11–5.PubMedCrossRef
54.
go back to reference Abolfazl Avan HRK, Tjaard U Hoogenraad. Initial zinc therapy in Wilson’s disease with acute liver failure and copper intoxication: a clinical observation. Abstracts of the Seventeenth International Congress of Parkinson’s Disease and Movement Disorders: Movement Disorder; 2–13. Abolfazl Avan HRK, Tjaard U Hoogenraad. Initial zinc therapy in Wilson’s disease with acute liver failure and copper intoxication: a clinical observation. Abstracts of the Seventeenth International Congress of Parkinson’s Disease and Movement Disorders: Movement Disorder; 2–13.
55.
go back to reference Hariharan D, Das MK, Shepard DS, Arora NK. Economic burden of dengue illness in India from 2013 to 2016: a systematic analysis. Int J Infect Dis. 2019;84S:S68–73.PubMedCrossRef Hariharan D, Das MK, Shepard DS, Arora NK. Economic burden of dengue illness in India from 2013 to 2016: a systematic analysis. Int J Infect Dis. 2019;84S:S68–73.PubMedCrossRef
56.
57.
go back to reference John J, Van Aart CJ, Grassly NC. The burden of typhoid and paratyphoid in India: systematic review and meta-analysis. PLoS Negl Trop Dis. 2016;10:e0004616. John J, Van Aart CJ, Grassly NC. The burden of typhoid and paratyphoid in India: systematic review and meta-analysis. PLoS Negl Trop Dis. 2016;10:e0004616.
58.
go back to reference Moola S, Beri D, Salam A, Jagnoor J, Teja A, Bhaumik S. Leptospirosis prevalence and risk factors in India: evidence gap maps. Trop Doct. 2021;51:415–21.PubMedCrossRef Moola S, Beri D, Salam A, Jagnoor J, Teja A, Bhaumik S. Leptospirosis prevalence and risk factors in India: evidence gap maps. Trop Doct. 2021;51:415–21.PubMedCrossRef
59.
go back to reference Anand AC, Garg HK. Approach to clinical syndrome of jaundice and encephalopathy in tropics. J Clin Exp Hepatol. 2015;5 Suppl 1:S116–30. Anand AC, Garg HK. Approach to clinical syndrome of jaundice and encephalopathy in tropics. J Clin Exp Hepatol. 2015;5 Suppl 1:S116–30.
60.
go back to reference Reynolds AS, Brush B, Schiano TD, Reilly KJ, Dangayach NS. Neurological monitoring in acute liver failure. Hepatology. 2019;70:1830–5.PubMedCrossRef Reynolds AS, Brush B, Schiano TD, Reilly KJ, Dangayach NS. Neurological monitoring in acute liver failure. Hepatology. 2019;70:1830–5.PubMedCrossRef
61.
go back to reference Chen JW, Gombart ZJ, Rogers S, Gardiner SK, Cecil S, Bullock RM. Pupillary reactivity as an early indicator of increased intracranial pressure: the introduction of the Neurological Pupil index. Surg Neurol Int. 2011;2:82. Chen JW, Gombart ZJ, Rogers S, Gardiner SK, Cecil S, Bullock RM. Pupillary reactivity as an early indicator of increased intracranial pressure: the introduction of the Neurological Pupil index. Surg Neurol Int. 2011;2:82.
62.
go back to reference Vijay P, Lal BB, Sood V, Khanna R, Patidar Y, Alam S. Dynamic Optic Nerve Sheath Diameter (ONSD) guided management of raised intracranial pressure in pediatric acute liver failure. Hepatol Int. 2021;15:502–9.PubMedCrossRef Vijay P, Lal BB, Sood V, Khanna R, Patidar Y, Alam S. Dynamic Optic Nerve Sheath Diameter (ONSD) guided management of raised intracranial pressure in pediatric acute liver failure. Hepatol Int. 2021;15:502–9.PubMedCrossRef
63.
go back to reference Bhardwaj A, Bhagat H, Grover VK. Jugular venous oximetry. J Neuroanaesthesiol Critical Care. 2015;2:225–31.CrossRef Bhardwaj A, Bhagat H, Grover VK. Jugular venous oximetry. J Neuroanaesthesiol Critical Care. 2015;2:225–31.CrossRef
64.
go back to reference Paschoal FM Jr, Nogueira RC, Ronconi Kde A, de Lima OM, Teixeira MJ, Bor-Seng-Shu E. Multimodal brain monitoring in fulminant hepatic failure. World J Hepatol. 2016;8:915–23. Paschoal FM Jr, Nogueira RC, Ronconi Kde A, de Lima OM, Teixeira MJ, Bor-Seng-Shu E. Multimodal brain monitoring in fulminant hepatic failure. World J Hepatol. 2016;8:915–23.
65.
go back to reference Hwang S, Lee SG, Park JI, et al. Continuous peritransplant assessment of consciousness using bispectral index monitoring for patients with fulminant hepatic failure undergoing urgent liver transplantation. Clin Transplant. 2010;24:91–7.PubMedCrossRef Hwang S, Lee SG, Park JI, et al. Continuous peritransplant assessment of consciousness using bispectral index monitoring for patients with fulminant hepatic failure undergoing urgent liver transplantation. Clin Transplant. 2010;24:91–7.PubMedCrossRef
67.
go back to reference Rajajee V, Williamson CA, Fontana RJ, Courey AJ, Patil PG. Noninvasive intracranial pressure assessment in acute liver failure. Neurocrit Care. 2018;29:280–90.PubMedCrossRef Rajajee V, Williamson CA, Fontana RJ, Courey AJ, Patil PG. Noninvasive intracranial pressure assessment in acute liver failure. Neurocrit Care. 2018;29:280–90.PubMedCrossRef
68.
go back to reference Kawakami M, Koda M, Murawaki Y. Cerebral pulsatility index by transcranial Doppler sonography predicts the prognosis of patients with fulminant hepatic failure. Clin Imaging. 2010;34:327–31.PubMedCrossRef Kawakami M, Koda M, Murawaki Y. Cerebral pulsatility index by transcranial Doppler sonography predicts the prognosis of patients with fulminant hepatic failure. Clin Imaging. 2010;34:327–31.PubMedCrossRef
69.
go back to reference Picard B, Sigaut S, Roux O, et al. Evaluation of transcranial Doppler use in patients with acute liver failure listed for emergency liver transplantation. Clin Transplant. 2023;37:e14975. Picard B, Sigaut S, Roux O, et al. Evaluation of transcranial Doppler use in patients with acute liver failure listed for emergency liver transplantation. Clin Transplant. 2023;37:e14975.
70.
go back to reference Reier L, Fowler JB, Arshad M, et al. Optic disc edema and elevated intracranial pressure (ICP): a comprehensive review of papilledema. Cureus. 2022;14:e24915. Reier L, Fowler JB, Arshad M, et al. Optic disc edema and elevated intracranial pressure (ICP): a comprehensive review of papilledema. Cureus. 2022;14:e24915.
71.
go back to reference Richards E, Munakomi S, Mathew D. Optic Nerve Sheath Ultrasound. 2023 Aug 13. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. Richards E, Munakomi S, Mathew D. Optic Nerve Sheath Ultrasound. 2023 Aug 13. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024.
72.
go back to reference Bhatia V, Batra Y, Acharya SK. Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure–a controlled clinical trial. J Hepatol. 2004;41:89–96.PubMedCrossRef Bhatia V, Batra Y, Acharya SK. Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure–a controlled clinical trial. J Hepatol. 2004;41:89–96.PubMedCrossRef
73.
go back to reference Benedetti GM, Guerriero RM, Press CA. Review of noninvasive neuromonitoring modalities in children II: EEG, qEEG. Neurocrit Care. 2023;39:618–38.PubMedCrossRef Benedetti GM, Guerriero RM, Press CA. Review of noninvasive neuromonitoring modalities in children II: EEG, qEEG. Neurocrit Care. 2023;39:618–38.PubMedCrossRef
74.
go back to reference Deep A, Alexander EC, Bulut Y, et al. Advances in medical management of acute liver failure in children: promoting native liver survival. Lancet Child Adolesc Health. 2022;6:725–37.PubMedCrossRef Deep A, Alexander EC, Bulut Y, et al. Advances in medical management of acute liver failure in children: promoting native liver survival. Lancet Child Adolesc Health. 2022;6:725–37.PubMedCrossRef
75.
go back to reference Newey CR, Sarwal A, Hantus S. Continuous electroencephalography (cEEG) changes precede clinical changes in a case of progressive cerebral edema. Neurocrit Care. 2013;18:261–5.PubMedCrossRef Newey CR, Sarwal A, Hantus S. Continuous electroencephalography (cEEG) changes precede clinical changes in a case of progressive cerebral edema. Neurocrit Care. 2013;18:261–5.PubMedCrossRef
76.
go back to reference Hussain E, Grimason M, Goldstein J, et al. EEG abnormalities are associated with increased risk of transplant or poor outcome in children with acute liver failure. J Pediatr Gastroenterol Nutr. 2014;58:449–56.PubMedCrossRef Hussain E, Grimason M, Goldstein J, et al. EEG abnormalities are associated with increased risk of transplant or poor outcome in children with acute liver failure. J Pediatr Gastroenterol Nutr. 2014;58:449–56.PubMedCrossRef
77.
go back to reference Ranjan P, Mishra AM, Kale R, Saraswat VA, Gupta RK. Cytotoxic edema is responsible for raised intracranial pressure in fulminant hepatic failure: in vivo demonstration using diffusion-weighted MRI in human subjects. Metab Brain Dis. 2005;20:181–92.PubMedCrossRef Ranjan P, Mishra AM, Kale R, Saraswat VA, Gupta RK. Cytotoxic edema is responsible for raised intracranial pressure in fulminant hepatic failure: in vivo demonstration using diffusion-weighted MRI in human subjects. Metab Brain Dis. 2005;20:181–92.PubMedCrossRef
78.
go back to reference Chavarria L, Alonso J, Rovira A, Cordoba J. Neuroimaging in acute liver failure. Neurochem Int. 2011;59:1175–80.PubMedCrossRef Chavarria L, Alonso J, Rovira A, Cordoba J. Neuroimaging in acute liver failure. Neurochem Int. 2011;59:1175–80.PubMedCrossRef
79.
go back to reference Jadaun SS, Sharma S, Madhusudhan KS, et al. Spectrum of neuroimaging abnormalities in brain in patients of acute-on-chronic liver failure. J Clin Exp Hepatol. 2022;12:343–52.PubMedCrossRef Jadaun SS, Sharma S, Madhusudhan KS, et al. Spectrum of neuroimaging abnormalities in brain in patients of acute-on-chronic liver failure. J Clin Exp Hepatol. 2022;12:343–52.PubMedCrossRef
80.
go back to reference Barber PA, Hill MD, Eliasziw M, et al. Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging. J Neurol Neurosurg Psychiatry. 2005;76:1528–33.PubMedPubMedCentralCrossRef Barber PA, Hill MD, Eliasziw M, et al. Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging. J Neurol Neurosurg Psychiatry. 2005;76:1528–33.PubMedPubMedCentralCrossRef
81.
go back to reference Vilela P, Rowley HA. Brain ischemia: CT and MRI techniques in acute ischemic stroke. Eur J Radio. 2017;96:162–72.CrossRef Vilela P, Rowley HA. Brain ischemia: CT and MRI techniques in acute ischemic stroke. Eur J Radio. 2017;96:162–72.CrossRef
83.
go back to reference Nakao M, Nakayama N, Uchida Y, et al. Nationwide survey for acute liver failure and late-onset hepatic failure in Japan. J Gastroenterol. 2018;53:752–69.PubMedCrossRef Nakao M, Nakayama N, Uchida Y, et al. Nationwide survey for acute liver failure and late-onset hepatic failure in Japan. J Gastroenterol. 2018;53:752–69.PubMedCrossRef
84.
go back to reference Bernal W, Hall C, Karvellas CJ, Auzinger G, Sizer E, Wendon J. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology. 2007;46:1844–52.PubMedCrossRef Bernal W, Hall C, Karvellas CJ, Auzinger G, Sizer E, Wendon J. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology. 2007;46:1844–52.PubMedCrossRef
85.
go back to reference Jayalakshmi VT, Bernal W. Update on the management of acute liver failure. Curr Opin Crit Care. 2020;26:163–70.PubMedCrossRef Jayalakshmi VT, Bernal W. Update on the management of acute liver failure. Curr Opin Crit Care. 2020;26:163–70.PubMedCrossRef
86.
go back to reference Mokri B. The Monro-Kellie hypothesis: applications in CSF volume depletion. Neurology. 2001;56:1746–8.PubMedCrossRef Mokri B. The Monro-Kellie hypothesis: applications in CSF volume depletion. Neurology. 2001;56:1746–8.PubMedCrossRef
87.
go back to reference Kalal CR, Maiwall R, Choudhary A, et al. Mannitol is comparable to hypertonic saline for raised intracranial pressure in acute liver failure (MAHAL Study): a randomized controlled trial. Dig Dis. 2022;40:607–15.PubMedCrossRef Kalal CR, Maiwall R, Choudhary A, et al. Mannitol is comparable to hypertonic saline for raised intracranial pressure in acute liver failure (MAHAL Study): a randomized controlled trial. Dig Dis. 2022;40:607–15.PubMedCrossRef
88.
go back to reference de Lacerda GCB. Treating seizures in renal and hepatic failure. J Epilepsy Clin Neurophysiol. 2008;14Suppl2:46–50. de Lacerda GCB. Treating seizures in renal and hepatic failure. J Epilepsy Clin Neurophysiol. 2008;14Suppl2:46–50.
89.
go back to reference Wijdicks EF, Nyberg SL. Propofol to control intracranial pressure in fulminant hepatic failure. Transplant Proc. 2002;34:1220–2.PubMedCrossRef Wijdicks EF, Nyberg SL. Propofol to control intracranial pressure in fulminant hepatic failure. Transplant Proc. 2002;34:1220–2.PubMedCrossRef
90.
go back to reference Ong JP, Aggarwal A, Krieger D, et al. Correlation between ammonia levels and the severity of hepatic encephalopathy. Am J Med. 2003;114:188–93.PubMedCrossRef Ong JP, Aggarwal A, Krieger D, et al. Correlation between ammonia levels and the severity of hepatic encephalopathy. Am J Med. 2003;114:188–93.PubMedCrossRef
91.
go back to reference Kramer L, Tribl B, Gendo A, et al. Partial pressure of ammonia versus ammonia in hepatic encephalopathy. Hepatology. 2000;31:30–4.PubMedCrossRef Kramer L, Tribl B, Gendo A, et al. Partial pressure of ammonia versus ammonia in hepatic encephalopathy. Hepatology. 2000;31:30–4.PubMedCrossRef
92.
go back to reference Cardoso FS, Gottfried M, Tujios S, Olson JC, Karvellas CJ, Group USALFS. Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure. Hepatology. 2018;67:711–20. Cardoso FS, Gottfried M, Tujios S, Olson JC, Karvellas CJ, Group USALFS. Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure. Hepatology. 2018;67:711–20.
93.
go back to reference Kumar R, Shalimar, Sharma H, et al. Persistent hyperammonemia is associated with complications and poor outcomes in patients with acute liver failure. Clin Gastroenterol Hepatol. 2012;10:925–31. Kumar R, Shalimar, Sharma H, et al. Persistent hyperammonemia is associated with complications and poor outcomes in patients with acute liver failure. Clin Gastroenterol Hepatol. 2012;10:925–31.
94.
go back to reference Acharya SK, Bhatia V, Sreenivas V, Khanal S, Panda SK. Efficacy of L-ornithine L-aspartate in acute liver failure: a double-blind, randomized, placebo-controlled study. Gastroenterology. 2009;136:2159–68.PubMedCrossRef Acharya SK, Bhatia V, Sreenivas V, Khanal S, Panda SK. Efficacy of L-ornithine L-aspartate in acute liver failure: a double-blind, randomized, placebo-controlled study. Gastroenterology. 2009;136:2159–68.PubMedCrossRef
95.
go back to reference Alba L, Hay J, Angulo P, Lee W. Lactulose therapy in acute liver failure. J Hepatol. 2002;36:33.CrossRef Alba L, Hay J, Angulo P, Lee W. Lactulose therapy in acute liver failure. J Hepatol. 2002;36:33.CrossRef
97.
go back to reference Als-Nielsen B, Koretz RL, Kjaergard LL, Gluud C. Branched-chain amino acids for hepatic encephalopathy. Cochrane Database Syst Rev. 2003:CD001939. Als-Nielsen B, Koretz RL, Kjaergard LL, Gluud C. Branched-chain amino acids for hepatic encephalopathy. Cochrane Database Syst Rev. 2003:CD001939.
98.
go back to reference Abenavoli L, Maurizi V, Boccuto L, et al. Nutritional support in acute liver failure. Diseases. 2022;10:108. Abenavoli L, Maurizi V, Boccuto L, et al. Nutritional support in acute liver failure. Diseases. 2022;10:108.
99.
go back to reference Belanger-Quintana A, Arrieta Blanco F, Barrio-Carreras D, et al. Recommendations for the diagnosis and therapeutic management of hyperammonaemia in paediatric and adult patients. Nutrients. 2022;14:2755. Belanger-Quintana A, Arrieta Blanco F, Barrio-Carreras D, et al. Recommendations for the diagnosis and therapeutic management of hyperammonaemia in paediatric and adult patients. Nutrients. 2022;14:2755.
100.
go back to reference Stravitz RT, Kramer DJ. Management of acute liver failure. Nat Rev Gastroenterol Hepatol. 2009;6:542–53.PubMedCrossRef Stravitz RT, Kramer DJ. Management of acute liver failure. Nat Rev Gastroenterol Hepatol. 2009;6:542–53.PubMedCrossRef
101.
go back to reference Larsen FS, Schmidt LE, Bernsmeier C, et al. High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial. J Hepatol. 2016;64:69–78.PubMedCrossRef Larsen FS, Schmidt LE, Bernsmeier C, et al. High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial. J Hepatol. 2016;64:69–78.PubMedCrossRef
102.
go back to reference Premkumar M, Kajal K, Kulkarni AV, Gupta A, Divyaveer S. Point-of-care echocardiography and hemodynamic monitoring in cirrhosis and acute-on-chronic liver failure in the COVID-19 era. J Intensive Care Med. 2021;36:511–23.PubMedCrossRef Premkumar M, Kajal K, Kulkarni AV, Gupta A, Divyaveer S. Point-of-care echocardiography and hemodynamic monitoring in cirrhosis and acute-on-chronic liver failure in the COVID-19 era. J Intensive Care Med. 2021;36:511–23.PubMedCrossRef
103.
go back to reference van Limmen J, Iturriagagoitia X, Verougstraete M, et al. Effect of norepinephrine infusion on hepatic blood flow and its interaction with somatostatin: an observational cohort study. BMC Anesthesiol. 2022;22:202. van Limmen J, Iturriagagoitia X, Verougstraete M, et al. Effect of norepinephrine infusion on hepatic blood flow and its interaction with somatostatin: an observational cohort study. BMC Anesthesiol. 2022;22:202.
104.
go back to reference Eefsen M, Dethloff T, Frederiksen HJ, Hauerberg J, Hansen BA, Larsen FS. Comparison of terlipressin and noradrenalin on cerebral perfusion, intracranial pressure and cerebral extracellular concentrations of lactate and pyruvate in patients with acute liver failure in need of inotropic support. J Hepatol. 2007;47:381–6.PubMedCrossRef Eefsen M, Dethloff T, Frederiksen HJ, Hauerberg J, Hansen BA, Larsen FS. Comparison of terlipressin and noradrenalin on cerebral perfusion, intracranial pressure and cerebral extracellular concentrations of lactate and pyruvate in patients with acute liver failure in need of inotropic support. J Hepatol. 2007;47:381–6.PubMedCrossRef
105.
go back to reference Shawcross DL, Davies NA, Mookerjee RP, et al. Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathy. Hepatology. 2004;39:471–5.PubMedCrossRef Shawcross DL, Davies NA, Mookerjee RP, et al. Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathy. Hepatology. 2004;39:471–5.PubMedCrossRef
106.
go back to reference Harry R, Auzinger G, Wendon J. The effects of supraphysiological doses of corticosteroids in hypotensive liver failure. Liver Int. 2003;23:71–7.PubMedCrossRef Harry R, Auzinger G, Wendon J. The effects of supraphysiological doses of corticosteroids in hypotensive liver failure. Liver Int. 2003;23:71–7.PubMedCrossRef
107.
go back to reference Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120:c179-84. Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120:c179-84.
108.
go back to reference Leithead JA, Ferguson JW, Bates CM, et al. The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure. Gut. 2009;58:443–9.PubMedCrossRef Leithead JA, Ferguson JW, Bates CM, et al. The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure. Gut. 2009;58:443–9.PubMedCrossRef
109.
110.
go back to reference Tujios SR, Hynan LS, Vazquez MA, et al. Risk factors and outcomes of acute kidney injury in patients with acute liver failure. Clin Gastroenterol Hepatol. 2015;13:352–9.PubMedCrossRef Tujios SR, Hynan LS, Vazquez MA, et al. Risk factors and outcomes of acute kidney injury in patients with acute liver failure. Clin Gastroenterol Hepatol. 2015;13:352–9.PubMedCrossRef
111.
go back to reference Davenport A, Will EJ, Davidson AM. Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure. Crit Care Med. 1993;21:328–38.PubMedCrossRef Davenport A, Will EJ, Davidson AM. Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure. Crit Care Med. 1993;21:328–38.PubMedCrossRef
112.
go back to reference Kappus MR. Acute hepatic failure and nutrition. Nutr Clin Pract. 2020;35:30–5.CrossRef Kappus MR. Acute hepatic failure and nutrition. Nutr Clin Pract. 2020;35:30–5.CrossRef
113.
go back to reference Shah AD, Wood DM, Dargan PI. Understanding lactic acidosis in paracetamol (acetaminophen) poisoning. British J Clin Pharmacol. 2011;71:20–8.CrossRef Shah AD, Wood DM, Dargan PI. Understanding lactic acidosis in paracetamol (acetaminophen) poisoning. British J Clin Pharmacol. 2011;71:20–8.CrossRef
114.
go back to reference Shalimar, Acharya SK. Management in acute liver failure. J Clin Exp Hepatol. 2015;5 Suppl 1:S104–15. Shalimar, Acharya SK. Management in acute liver failure. J Clin Exp Hepatol. 2015;5 Suppl 1:S104–15.
115.
go back to reference Moore JK, Love E, Craig DG, Hayes PC, Simpson KJ. Acute kidney injury in acute liver failure: a review. Expert Rev Gastroenterol Hepatol. 2013;7:701–12.PubMedCrossRef Moore JK, Love E, Craig DG, Hayes PC, Simpson KJ. Acute kidney injury in acute liver failure: a review. Expert Rev Gastroenterol Hepatol. 2013;7:701–12.PubMedCrossRef
116.
go back to reference Kramer AH, Roberts DJ, Zygun DA. Optimal glycemic control in neurocritical care patients: a systematic review and meta-analysis. Crit Care. 2012;16:R203. Kramer AH, Roberts DJ, Zygun DA. Optimal glycemic control in neurocritical care patients: a systematic review and meta-analysis. Crit Care. 2012;16:R203.
117.
go back to reference Stroud M, Duncan H, Nightingale J. Guidelines for enteral feeding in adult hospital patients. Gut. 2003;52 Suppl 7:vii1-vii12. Stroud M, Duncan H, Nightingale J. Guidelines for enteral feeding in adult hospital patients. Gut. 2003;52 Suppl 7:vii1-vii12.
118.
go back to reference Baquerizo A, Anselmo D, Shackleton C, et al. Phosphorus ans an early predictive factor in patients with acute liver failure. Transplantation. 2003;75:2007–14.PubMedCrossRef Baquerizo A, Anselmo D, Shackleton C, et al. Phosphorus ans an early predictive factor in patients with acute liver failure. Transplantation. 2003;75:2007–14.PubMedCrossRef
120.
go back to reference Antoniades CG, Berry PA, Davies ET, et al. Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure. Hepatology. 2006;44:34–43.PubMedCrossRef Antoniades CG, Berry PA, Davies ET, et al. Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure. Hepatology. 2006;44:34–43.PubMedCrossRef
121.
go back to reference Rolando N, Harvey F, Brahm J, et al. Fungal infection: a common, unrecognised complication of acute liver failure. J Hepatol. 1991;12:1–9.PubMedCrossRef Rolando N, Harvey F, Brahm J, et al. Fungal infection: a common, unrecognised complication of acute liver failure. J Hepatol. 1991;12:1–9.PubMedCrossRef
123.
go back to reference Kaur P, Verma N, Valsan A, et al. Prevalence, risk factors, and impact of bacterial or fungal infections in acute liver failure patients from India. Dig Dis Sci. 2023;68:4022–38.PubMedCrossRef Kaur P, Verma N, Valsan A, et al. Prevalence, risk factors, and impact of bacterial or fungal infections in acute liver failure patients from India. Dig Dis Sci. 2023;68:4022–38.PubMedCrossRef
124.
go back to reference Karvellas CJ, Cavazos J, Battenhouse H, et al. Effects of antimicrobial prophylaxis and blood stream infections in patients with acute liver failure: a retrospective cohort study. Clin Gastroenterol Hepatol. 2014;12:1942-9. e1. Karvellas CJ, Cavazos J, Battenhouse H, et al. Effects of antimicrobial prophylaxis and blood stream infections in patients with acute liver failure: a retrospective cohort study. Clin Gastroenterol Hepatol. 2014;12:1942-9. e1.
125.
go back to reference Vaquero J, Polson J, Chung C, et al. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology. 2003;125:755–64.PubMedCrossRef Vaquero J, Polson J, Chung C, et al. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology. 2003;125:755–64.PubMedCrossRef
126.
go back to reference Church DL, Cerutti L, Gurtler A, Griener T, Zelazny A, Emler S. Performance and application of 16S rRNA gene cycle sequencing for routine identification of bacteria in the clinical microbiology laboratory. Clin Microbiol Rev. 2020;33:e00053-19. Church DL, Cerutti L, Gurtler A, Griener T, Zelazny A, Emler S. Performance and application of 16S rRNA gene cycle sequencing for routine identification of bacteria in the clinical microbiology laboratory. Clin Microbiol Rev. 2020;33:e00053-19.
127.
go back to reference Fernández J, Piano S, Bartoletti M, Wey EQ. Management of bacterial and fungal infections in cirrhosis: the MDRO challenge. J Hepatol. 2021;75 Suppl 1:S101-s17. Fernández J, Piano S, Bartoletti M, Wey EQ. Management of bacterial and fungal infections in cirrhosis: the MDRO challenge. J Hepatol. 2021;75 Suppl 1:S101-s17.
128.
go back to reference Keighley C, Cooley L, Morris AJ, et al. Consensus guidelines for the diagnosis and management of invasive candidiasis in haematology, oncology and intensive care settings, 2021. Intern Med J. 2021;51Suppl 7:89–117.PubMedCrossRef Keighley C, Cooley L, Morris AJ, et al. Consensus guidelines for the diagnosis and management of invasive candidiasis in haematology, oncology and intensive care settings, 2021. Intern Med J. 2021;51Suppl 7:89–117.PubMedCrossRef
129.
go back to reference Douglas AP, Smibert OC, Bajel A, et al. Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021. Intern Med J. 2021;51Suppl 7:143–76.PubMedCrossRef Douglas AP, Smibert OC, Bajel A, et al. Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021. Intern Med J. 2021;51Suppl 7:143–76.PubMedCrossRef
131.
go back to reference Hsu AJ, Tamma PD, Zhang SX. Challenges with utilizing the 1,3-beta-d-glucan and galactomannan assays to diagnose invasive mold infections in immunocompromised children. J Clin Microbiol. 2021;59:e0327620. Hsu AJ, Tamma PD, Zhang SX. Challenges with utilizing the 1,3-beta-d-glucan and galactomannan assays to diagnose invasive mold infections in immunocompromised children. J Clin Microbiol. 2021;59:e0327620.
132.
133.
go back to reference Freire MP, Oshiro IC, Pierrotti LC, et al. Carbapenem-resistant Enterobacteriaceae acquired before liver transplantation: impact on recipient outcomes. Transplantation. 2017;101:811–20.PubMedPubMedCentralCrossRef Freire MP, Oshiro IC, Pierrotti LC, et al. Carbapenem-resistant Enterobacteriaceae acquired before liver transplantation: impact on recipient outcomes. Transplantation. 2017;101:811–20.PubMedPubMedCentralCrossRef
134.
go back to reference Stravitz RT, Fontana RJ, Meinzer C, et al. Coagulopathy, bleeding events, and outcome according to rotational thromboelastometry in patients with acute liver injury/failure. Hepatology. 2021;74:937–49.PubMedCrossRef Stravitz RT, Fontana RJ, Meinzer C, et al. Coagulopathy, bleeding events, and outcome according to rotational thromboelastometry in patients with acute liver injury/failure. Hepatology. 2021;74:937–49.PubMedCrossRef
135.
go back to reference Lisman T, Bakhtiari K, Adelmeijer J, Meijers JC, Porte RJ, Stravitz RT. Intact thrombin generation and decreased fibrinolytic capacity in patients with acute liver injury or acute liver failure. J Thromb Haemost. 2012;10:1312–9.PubMedCrossRef Lisman T, Bakhtiari K, Adelmeijer J, Meijers JC, Porte RJ, Stravitz RT. Intact thrombin generation and decreased fibrinolytic capacity in patients with acute liver injury or acute liver failure. J Thromb Haemost. 2012;10:1312–9.PubMedCrossRef
137.
go back to reference Ozbay Hosnut F, Ozcay F, Selda Bayrakci U, Avci Z, Özbek N. Etiology of hemolysis in two patients with hepatitis A infection: glucose-6-phosphate dehydrogenase deficiency or autoimmune hemolytic anemia. Eur J Pedia. 2008;167:1435–9.CrossRef Ozbay Hosnut F, Ozcay F, Selda Bayrakci U, Avci Z, Özbek N. Etiology of hemolysis in two patients with hepatitis A infection: glucose-6-phosphate dehydrogenase deficiency or autoimmune hemolytic anemia. Eur J Pedia. 2008;167:1435–9.CrossRef
138.
go back to reference Bhutra A, Giri PP, Ganguly N. Acute hepatic failure with hemolytic anemia due to hepatitis A infection with coexistent glucose-6-phosphate dehydrogenase deficiency. Pediat Infectious Dis. 2015;7:50–2.CrossRef Bhutra A, Giri PP, Ganguly N. Acute hepatic failure with hemolytic anemia due to hepatitis A infection with coexistent glucose-6-phosphate dehydrogenase deficiency. Pediat Infectious Dis. 2015;7:50–2.CrossRef
139.
go back to reference Premkumar M, Kulkarni AV, Kajal K, Divyaveer S. Principles, interpretation, and evidence-based role of viscoelastic point-of-care coagulation assays in cirrhosis and liver failure. J Clin Exp Hepatol. 2022;12:533–43.PubMedCrossRef Premkumar M, Kulkarni AV, Kajal K, Divyaveer S. Principles, interpretation, and evidence-based role of viscoelastic point-of-care coagulation assays in cirrhosis and liver failure. J Clin Exp Hepatol. 2022;12:533–43.PubMedCrossRef
140.
go back to reference Larson AM, Polson J, Fontana RJ, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 2005;42:1364–72.PubMedCrossRef Larson AM, Polson J, Fontana RJ, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 2005;42:1364–72.PubMedCrossRef
141.
go back to reference Maiwall R, Bajpai M, Singh A, et al. Standard-volume plasma exchange improves outcomes in patients with acute liver failure: a randomized controlled trial. Clin Gastroenterol Hepatol. 2022;20:e831–54. Maiwall R, Bajpai M, Singh A, et al. Standard-volume plasma exchange improves outcomes in patients with acute liver failure: a randomized controlled trial. Clin Gastroenterol Hepatol. 2022;20:e831–54.
142.
go back to reference Goel A, Zachariah U, Daniel D, Eapen CE. Growing evidence for survival benefit with plasma exchange to treat liver failure. J Clin Exp Hepatol. 2023;13:1061–73.PubMedCrossRef Goel A, Zachariah U, Daniel D, Eapen CE. Growing evidence for survival benefit with plasma exchange to treat liver failure. J Clin Exp Hepatol. 2023;13:1061–73.PubMedCrossRef
143.
go back to reference Thomas L, Chandran J, Goel A, et al. Improving transplant-free survival with low-volume plasma exchange to treat children with rodenticide induced hepatotoxicity. J Clin Exp Hepatol. 2023;13:252–8.PubMedCrossRef Thomas L, Chandran J, Goel A, et al. Improving transplant-free survival with low-volume plasma exchange to treat children with rodenticide induced hepatotoxicity. J Clin Exp Hepatol. 2023;13:252–8.PubMedCrossRef
144.
go back to reference Larsen FS, Ejlersen E, Hansen BA, Mogensen T, Tygstrup N, Secher NH. Systemic vascular resistance during high-volume plasmapheresis in patients with fulminant hepatic failure: relationship with oxygen consumption. Eur J Gastroenterol Hepatol. 1995;7:887–92.PubMed Larsen FS, Ejlersen E, Hansen BA, Mogensen T, Tygstrup N, Secher NH. Systemic vascular resistance during high-volume plasmapheresis in patients with fulminant hepatic failure: relationship with oxygen consumption. Eur J Gastroenterol Hepatol. 1995;7:887–92.PubMed
145.
go back to reference Govindarajan R, Ramamoorthy G, Shanmugam RM, et al. Rodenticide ingestion is an important cause of acute hepatotoxicity in Tamil Nadu, southern India. Indian J Gastroenterol. 2021;40:373–9.PubMedCrossRef Govindarajan R, Ramamoorthy G, Shanmugam RM, et al. Rodenticide ingestion is an important cause of acute hepatotoxicity in Tamil Nadu, southern India. Indian J Gastroenterol. 2021;40:373–9.PubMedCrossRef
146.
go back to reference O’Keefe SJ, El-Zayadi AR, Carraher TE, Davis M, Williams R. Malnutrition and immuno-incompetence in patients with liver disease. Lancet. 1980;2 pt 1:615–7. O’Keefe SJ, El-Zayadi AR, Carraher TE, Davis M, Williams R. Malnutrition and immuno-incompetence in patients with liver disease. Lancet. 1980;2 pt 1:615–7.
148.
149.
go back to reference Blot SI, Poelaert J, Kollef M. How to avoid microaspiration? A key element for the prevention of ventilator-associated pneumonia in intubated ICU patients. BMC Infect Dis. 2014;14:119. Blot SI, Poelaert J, Kollef M. How to avoid microaspiration? A key element for the prevention of ventilator-associated pneumonia in intubated ICU patients. BMC Infect Dis. 2014;14:119.
150.
go back to reference Chase RA, Davies M, Trewby PN, Silk DB, Williams R. Plasma amino acid profiles in patients with fulminant hepatic failure treated by repeated polyacrylonitrile membrane hemodialysis. Gastroenterology. 1978;75:1033–40.PubMedCrossRef Chase RA, Davies M, Trewby PN, Silk DB, Williams R. Plasma amino acid profiles in patients with fulminant hepatic failure treated by repeated polyacrylonitrile membrane hemodialysis. Gastroenterology. 1978;75:1033–40.PubMedCrossRef
151.
go back to reference Mallick S, Nair K, Thillai M, et al. Liver transplant in acute liver failure - looking back over 10 years. J Clin Exp Hepatol. 2020;10:322–8.PubMedCrossRef Mallick S, Nair K, Thillai M, et al. Liver transplant in acute liver failure - looking back over 10 years. J Clin Exp Hepatol. 2020;10:322–8.PubMedCrossRef
152.
go back to reference Mehrotra S, Mehta N, Rao PS, Lalwani S, Mangla V, Nundy S. Live donor liver transplantation for acute liver failure: a single center experience. Indian J Gastroenterol. 2018;37:25–30.PubMedCrossRef Mehrotra S, Mehta N, Rao PS, Lalwani S, Mangla V, Nundy S. Live donor liver transplantation for acute liver failure: a single center experience. Indian J Gastroenterol. 2018;37:25–30.PubMedCrossRef
153.
go back to reference Pamecha V, Vagadiya A, Sinha PK, et al. Living donor liver transplantation for acute liver failure: donor safety and recipient outcome. Liver Transpl. 2019;25:1408–21.PubMedCrossRef Pamecha V, Vagadiya A, Sinha PK, et al. Living donor liver transplantation for acute liver failure: donor safety and recipient outcome. Liver Transpl. 2019;25:1408–21.PubMedCrossRef
Metadata
Title
Critical care management of acute liver failure
Authors
Surender Singh Sehrawat
Madhumita Premkumar
Publication date
05-04-2024
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.